Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial data and shared its interim analysis with the trial…